Usefulness of postischemic thrombolysis with or without neuroprotection in a focal embolic model of cerebral ischemia

Journal of Neurosurgery

Volumn 92, Issue 5, 2000, Pages 841-847

  Yang, Yi ^a   Li, Qiu ^b   Miyashita, Hero ^b   Howlett, Wendy ^b   Siddiqui, Muzaffar ^b   Shuaib, Ashfaq ^b  

^a UNIVERSITY OF ALBERTA   (Canada)

^b NONE

Author keywords

Cerebral ischemia; Hemorrhage; Intracerebral; Rat; Thrombolysis urokinase

Indexed keywords

FIBRINOLYTIC AGENT; TOPIRAMATE; UROKINASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD CLOT LYSIS; BRAIN EMBOLISM; BRAIN HEMORRHAGE; BRAIN INFARCTION; BRAIN ISCHEMIA; CONTROLLED STUDY; DRUG EFFICACY; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; RAT; STROKE; TREATMENT OUTCOME;

EID: 0034055358     PISSN: 00223085     EISSN: None     Source Type: Journal    
DOI: 10.3171/jns.2000.92.5.0841     Document Type: Article

References (40)

1. Aronowski J, Stroke R, Grotta JC: Combined neuroprotection and reperfusion therapy for stroke. Effects of lubeluzole and di-aspirin cross-linked hemoglobin in experimental focal ischemia. Stroke 27:1571-1577, 1996
2. Bederson JB, Pitts LH, Tsuji M, et al: Rat middle cerebral artery occlusion: evaluation of the model and development of a neurologic examination. Stroke 17:472-476, 1986
3. Bednar MM, Raymond SJ, Gross CE: Tissue plasminogen activator: comparison of dose and route of administration in a rabbit model of thromboembolic stroke. Neurol Res 15:405-408, 1993
4. Bourgeois BFD: New antiepileptic drugs. Curr Opin Pediatr 8:543-548, 1996
5. Bowes MP, Zivin JA, Thomas GR, et al: Acute hypertension but not thrombolysis, increases the incidence and severity of hemorrhagic transformation following experimental stroke in rabbits. Exp Neurol 141:40-46, 1996
6. Del Zoppo GJ: Thrombolytic therapy in acute stroke: recent experience. Cerebrovasc Dis 3:256-263, 1993
7. Duverger D, MacKenzie ET: The quantification of cerebral infarction following focal ischemia in the rat: influence of strain, arterial pressure, blood glucose concentration, and age. J Cereb Blood Flow Metab 8:449-461, 1988
8. European Cooperative Acute Stroke Study (ECASS): Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke. JAMA 274:1017-1025, 1995
9. Holland JP, Sydserff SGC, Taylor WAS, et al: Calcitonin gene-related peptide reduces brain injury in a rat model of focal cerebral ischemia. Stroke 25:2055-2059, 1994
10. Jichici D, Frank JI: Thrombolytic therapy in neurointensive care. Update Neurol Crit Care 13:201-227, 1997
11. Juurlink BHJ, Hertz L: Ischemia-induced death of astrocytes and neurons in primary culture: pitfalls in quantifying neuronal cell death. Dev Brain Res 71:239-246, 1993
12. Li PA, He QP, Siddiqui MM, et al: Posttreatment with low molecular weight heparin reduces brain edema and infarction volume in rats subjected to thrombotic middle cerebral artery occlusion. Brain Res 801:220-223, 1998
13. Lin TN, He YY, Wu G, et al: Effects of brain edema on infarct volume in a focal cerebral ischemia model in rats. Stroke 24: 117-121, 1993
14. Lippert K, Welsch M, Krieglstein J: Over-addictive protective effect of dizocilpine and NBQX against neuronal damage. Eur J Pharmacol 253:207-213, 1994
15. Lyden PD, Lonzo L: Combination therapy protects ischemic brain in rats. A glutamate antagonist plus a γ-aminobutyric acid agonist. Stroke 25:189-196, 1994
16. Meden P, Overgaard K, Pedersen H, et al: Effect of hypothermia and delayed thrombolysis in rat embolic stroke model. Acta Neurol Scand 90:91-98, 1994
17. Meden P, Overgaard K, Pedersen H, et al: Effects of early treatment with tirilizad combined with delayed thrombolytic therapy in rat embolic model. Cerebrovasc Dis 6:141-148, 1996
18. National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group: Tissue plasminogen activator for acute ischemic stroke. N Engl J Med 333:1581-1587, 1995
19. Nedergaard M: Mechanisms of brain damage in focal cerebral ischemia. Acta Neurol Scand 77:81-101, 1998
20. Orozco J, Mendal RC, Hahn MR, et al: Influence of a 'brain protector' drug 21-amino steroid on the effects of experimental embolic stroke treated by thrombolysis. Neurol Res 17: 423-425, 1995
21. Osborne KA, Shigeno T, Balarsky AM, et al: Quantitative assessment of early brain damage in a rat model of focal cerebral ischaemia. J Neurol Neurosurg Psychiatry 50:402-410, 1987
22. Overgaard K: Thrombolytic therapy in experimental embolic stroke. Cerebrovasc Brain Metab Rev 6:257-286, 1994
23. Overgaard K, Sereghy T, Boysen G, et al: Reduction of infarct volume and mortality by thrombolysis in a rat embolic stroke model. Stroke 23:1167-1174, 1992
24. Overgaard K, Sereghy T, Pedersen H, et al: Effect of delayed thrombolysis with rt-PA in a rat embolic stroke. J Cereb Blood Flow Metab 14:472-477, 1994
25. Overgaard K, Sereghy T, Pedersen H, et al: Neuroprotection with NBQX and thrombolysis with rt-PA in rat embolic stroke. Neurol Res 15:344-349, 1993
26. Rosenfeld WE: Topiramate: a review of preclinical, pharmacokinetic, and clinical data. Clin Ther 19:1294-1308, 1523-1524, 1997
27. Sander JWAS: Practical aspects of the use of topiramate in patients with epilepsy. Epilepsia 38 (Suppl 1):S56-S58, 1997
28. Shuaib A, Ijaz S, Mazagri R, et al: CGS-19755 is neuroprotective during repetitive ischemia: this effect is significantly enhanced when combined with hypothermia. Neuroscience 56: 915-920, 1993
29. Shuaib A, Yang Y, Li Q, et al: Intraarterial urokinase produces significant attenuation of infarction volume in an embolic focal ischemia model. Exp Neurol 154:330-335, 1998
30. Siesjö BK: Pathophysiology and treatment of focal cerebral ischemia. Part I: Pathophysiology. J Neurosurg 77:169-184, 1992
31. Siesjö BK: Pathophysiology and treatment of focal cerebral ischemia. Part II: Mechanisms of damage and treatment. J Neurosurg 77:337-354, 1992
32. Thomas GR, Thibodeaux H, Bennet WF, et al: Optimized thrombolysis of cerebral clots with tissue-type plasminogen activator in a rabbit model of embolic stroke. J Pharmacol Exp Ther 264:67-73, 1993
33. Truelove D, Shuaib A, Ijaz S, et al: Superoxide dismutase, catalase and U78517/F attenuate neuronal damage in gerbils with repeated brief ischemic insults. Neurochem Res 19:665-671, 1994
34. Wardlaw JM, Warlow CP: Thrombolysis in acute ischemic stroke: does it work? Stroke 23:1826-1839, 1992
35. Wauquier A, Zhou S: Topiramate: a potent anticonvulsant in the amygdala-kindled rat. Epilepsy Res 24:73-77, 1996
36. White HS: Clinical significance of animal seizure models and mechanism of action studies of potential antiepileptic drugs. Epilepsia 38 (Suppl 1):S9-S17, 1997
37. Yamaguchi M, Hayakawa T, Kiuchi H: Japanese thrombolysis study group: intravenous tissue plasminogen activator amelio-rated the outcome of hyperacute embolic stroke. Cerebrovasc Dis 3:269-273, 1993
38. Yang Y, Shuaib A, Li Q: Quantification of infarct size in focal cerebral ischemia model of rats using a simple and economical method. J Neurosci Methods 84:9-16, 1998
39. Yang Y, Shuaib A, Li Q, et al: Neuroprotection by delayed administration of topiramate in a rat model of middle cerebral artery embolization. Brain Res 804:169-176, 1998
40. Zhang Z, Zhang RL, Jiang Q, et al: A new rat model of thrombotic focal cerebral ischemia. J Cereb Blood Flow Metab 17: 123-135, 1997